David Shalowitz, MD, MSHP, emphasizes spreading awareness of opportunistic salpingectomy across specialties while grounding its use in shared decision-making.
|Podcasts|February 19, 2021
S3E2: HPV and cervical cancer with Sangini Sheth, MD, MPH
Author(s)Lindsey Carr, Editor
On this episode of Pap Talk, Sangini Sheth, MD, MPH discusses the latest research in cervical cancer and HPV.
Advertisement
Sheth is Associate Professor, Obstetrics, Gynecology and Reproductive Sciences; Associate Medical Director & Director of Colposcopy and Cervical Dysplasia, Women's Center, at Yale New Haven Hospital.
Advertisement
Related to this article
David Shalowitz, MD, MSHP, describes how OB-GYNs can collaborate with non-gynecologic surgeons to extend salpingectomy and reduce ovarian cancer risk during other abdominal procedures.
A new book from Sameena Rahman, MD, reclaims "brown girls' disease" as a lens for examining how dismissal—of conditions, anatomy, and patients—undermines sexual medicine care for all women.
The FDA approved an IDE allowing Mercy BioAnalytics to evaluate its Evident blood-based ovarian cancer screening test in the prospective pivotal SOARA study of average-risk women.
Sameena Rahman, MD, discusses how digital symptom trackers can shorten PMOS diagnostic delays and support earlier cardiometabolic care.
A new, expert-led video series explores the PCOS-to-PMOS rename and what it means for diagnosis, care, and outcomes.
A new SFP Committee Statement in Contraception standardizes protocols for removing deep and nonpalpable contraceptive implants.
Atogepant reduced perimenstrual migraine days vs. placebo and met all 8 secondary endpoints in the Phase 3 LUNA study.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Contemporary OB/GYN launches 'Missed & Dismissed' podcast to explore diagnostic gaps in women's health
2
Menopause proteomic scores associated with cognitive aging, dementia risk
3
CD38 is tied to age-related placental NAD+ decline in preclinical study
4
Zuranolone shows sustained PPD symptom improvement through day 90
5